Recruiting nowPhase 3
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Updated 2026-09-02 · NCT07083154See eligibility →
Sponsor
Active studies whose public registry record names The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.